1. Early Implantation as a Main Predictor of Response to Vagus Nerve Stimulation in Childhood-Onset Refractory Epilepsy
- Author
-
John Ragheb, Trevor Resnick, Antonella Pini, Ann Hyslop, Daniela Chiarello, Duccio Maria Cordelli, Mario Lima, Angelo Russo, Prasanna Jayakar, Mino Zucchelli, Michael Duchowny, Tullio Messana, Valentina Gentile, Ian Miller, Russo A., Hyslop A., Gentile V., Chiarello D., Messana T., Miller I., Zucchelli M., Lima M., Ragheb J., Pini A., Cordelli D.M., Resnick T., Jayakar P., and Duchowny M.
- Subjects
Male ,Drug Resistant Epilepsy ,Adolescent ,Vagus Nerve Stimulation ,medicine.medical_treatment ,Vagus nerve stimulator ,03 medical and health sciences ,Epilepsy ,0302 clinical medicine ,Humans ,Medicine ,0501 psychology and cognitive sciences ,050102 behavioral science & comparative psychology ,Child ,Retrospective Studies ,business.industry ,05 social sciences ,Age Factors ,Infant ,drug-resistant childhood epilepsy ,medicine.disease ,outcome predictor ,Treatment Outcome ,Child, Preschool ,Anesthesia ,Pediatrics, Perinatology and Child Health ,Refractory epilepsy ,Female ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Vagus nerve stimulation - Abstract
Objective: We describe a multicenter experience with vagus nerve stimulator implantation in pediatric patients with drug-resistant epilepsy. Our goal was to assess vagus nerve stimulation efficacy and identify potential predictors of favorable outcome. Methods: This is a retrospective study. Inclusion criteria: ≤18 years at time of vagus nerve stimulator implantation, at least 1 year of follow-up. All patients were previously found to be unsuitable for an excisional procedure. Favorable clinical outcome and effective vagus nerve stimulation therapy were defined as seizure reduction >50%. Outcome data were reviewed at 1, 2, 3, and 5 years after vagus nerve stimulator implantation. Fisher exact test and multiple logistic regression analysis were employed. Results: Eighty-nine patients met inclusion criteria. Responder rate (seizure frequency reduction >50%) at 1-year follow-up was 25.8% (4.5% seizure-free). At last follow-up, 31.5% had a favorable outcome and 5.2% were seizure free. The only factor significantly predicting favorable outcome was time to vagus nerve stimulator implantation, with the best outcome achieved when vagus nerve stimulator implantation was performed within 3 years of seizure onset. Implantation between 3 and 5 years after epilepsy onset correlated with better long-term seizure freedom (13.3% at T5). Overall, 65.2% of patients evidenced improved quality of life at last follow-up. However, 12.4% had adverse events, but most were mild and disappeared after 3-4 months. Conclusions: Early vagus nerve stimulator implantation within 5 years of seizure onset was the only predictor of favorable clinical outcome in pediatric patients. Improved quality of life and a low incidence of significant adverse events were observed.
- Published
- 2020
- Full Text
- View/download PDF